Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis. - Wikidata - wikimedia - TriplyDB

Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis.

Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis.

http://www.wikidata.org/entity/Q38133703

about

Capitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseases Lipid Droplets in Health and Disease.Novel mutation in a patient with cholesterol ester storage disease.Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease Degradation and beyond: the macrophage lysosome as a nexus for nutrient sensing and processing in atherosclerosis.A case of abdominal pain with dyslipidemia: difficulties diagnosing cholesterol ester storage disease.Perspectives in Pediatric Pathology, Chapter 21. Testicular Pathology in Heritable Metabolic Disease.Genetics of familial hypercholesterolemia.Quantitation of the rates of hepatic and intestinal cholesterol synthesis in lysosomal acid lipase-deficient mice before and during treatment with ezetimibe.Target acquired: Selective autophagy in cardiometabolic disease.Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD).Presumptive Spontaneous Lysosomal Storage-Like Disease in a Crl:CD1(ICR) Mouse.

P2860

Q26862688-08418628-8C40-4994-AA77-D3087A7BDA94 Q32174749-1D7D6ED1-3801-4463-A6DD-F46A5B472709 Q35101320-EB5E7F10-342B-4E9B-B248-8BAF160BD946 Q35947534-B6AD4CE1-8DF7-48BB-B030-3E418472E90F Q37265183-DD000FE9-12CB-4262-A3D3-E1DE17B21CAC Q37394917-A966992E-AA8D-44DB-A66B-F83FEBE8D7F5 Q38264149-5866A1DA-DE91-456A-A352-59384B2157F7 Q38364881-640E3081-C563-4196-8CA8-077F91F09CB7 Q38891202-A481AF3D-4C2B-4C08-9930-D6F54083A2D1 Q39155198-46081138-ADB7-402E-86D9-6CDA4A41DD34 Q39371640-AD388E44-2ABA-450C-BB84-A2BC9D260D31 Q40323432-4E0F89D1-B686-45E6-A9FA-3C5A95EC322A

P2860

Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis.

http://www.wikidata.org/entity/Q38133703

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cholesteryl ester storage dise ...... ascular disease and cirrhosis.

@en

type

label

Cholesteryl ester storage dise ...... ascular disease and cirrhosis.

@en

prefLabel

Cholesteryl ester storage dise ...... ascular disease and cirrhosis.

@en

P1433

Q38133703-9EF17B78-0F2F-474D-8C45-DC7AC987DC8B

P1476

Q38133703-E6FD9EA5-C30B-4B52-933E-8D4A5DB6F5EF

P2093

Q38133703-75C50041-FC65-4E00-94F5-F31C55C18FD5

P2860

Q38133703-06F3E8A2-90A1-47B0-8B56-8832ACA987A5

Q38133703-08FE78F7-5B4A-4E78-ADCF-6BB93E103601

Q38133703-0A7729D6-B263-43FD-9925-8A8B7C7F7507

Q38133703-0B7EE0B5-EB52-4A8F-958E-CEB11631EB7B

Q38133703-120AE1C5-1D45-4FDD-92AD-BD741506BF2E

Q38133703-1CDFBA8D-FE7F-451E-A301-C6AE2D43BB9F

Q38133703-44A511C4-8167-446B-B8C4-6610FE9D4F6B

Q38133703-4BE03C11-4ADF-46F2-8FD8-904CC4CF267F

Q38133703-512003B8-CF7C-4CE0-A29B-6A337AFB309B

Q38133703-51A08FED-029D-4713-A1B0-3255F1FC9478

P304

Q38133703-87C536FF-55D5-401E-8F3E-9F73F4D587F4

P31

Q38133703-480C398A-3788-450D-BC6A-5808D9824D68

P356

Q38133703-8B9E641B-8289-4C16-B201-37E9891225BE

P407

Q38133703-B337A969-8016-4BE8-AAE1-B35BA2AA3186

P433

Q38133703-D18F89F7-390C-490D-A72A-D5606B9D6B09

P478

Q38133703-7A7C6B78-D877-443A-8848-951FF3ABD316

P577

Q38133703-DC604A53-AA1D-47BF-B6AA-D2ADE427DA54

P698

Q38133703-CB7C0E7C-1AC8-41A9-A3A2-F40B577C04A2

P356

JCLINPATH-2012-201302

P1433

Journal of Clinical Pathology

P1476

Cholesteryl ester storage dise ...... ascular disease and cirrhosis.

@en

P2093

Tim Reynolds

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease.

Accumulated lipids, aberrant fatty acid composition and defective cholesterol ester hydrolase activity in cholesterol ester storage disease

Visualization of TGN to endosome trafficking through fluorescently labeled MPR and AP-1 in living cells

Phenotypic correction of lipid storage and growth arrest in wolman disease fibroblasts by gene transfer of lysosomal acid lipase.

A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy

Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease.

Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report.

Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.

P304

918-923

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCLINPATH-2012-201302

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23999269

http://www.w3.org/2001/XMLSchema#string